Utility of the revised cardiac risk index for predicting postsurgical morbidity in Hb SC and Hb Sβ+-thalassemia sickle cell disease.

ABSTRACT:

SUBMITTER: Rosenberg A 

PROVIDER: S-EPMC5377925 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature